SREBF1 and metabolic dysfunction-associated steatohepatitis: Therefore, to determine whether a NASH-induced target was regulated by SREBP-1c independent of lipid accumulation, we first evaluated gene expression following liver damage induced by acute CCl4 administration, which is a robust model of liver fibrosis with a reduced effect on lipid accumulation.